Clinical Trials

Disclaimer: The information in the links below is not provided by Ambit Biosciences Corporation but by a third party and is not intended to be relied on for investment purposes. Ambit Biosciences Corporation does not guarantee the accuracy or completeness of this information and is not liable for any delays, inaccuracies, errors in, or omissions of any such information, or for any actions taken in reliance on this information, or for any damages arising therefrom.


Quizartinib (AC220)




AC430/AC410 (JAK2)